Manulife shares are trading sharply lower today as investors reprice the stock following a wave of lowered sell-side expectations for 2026 revenue. The key catalyst is a reset in analysts’ statutory revenue forecasts, with cuts of roughly 13% for the year, which reduces confidence in the pace of growth across Manulife’s core earnings engines and increases sensitivity to any further estimate drift. (simplywall.st)

For life insurers and wealth managers, top-line expectations shape sentiment around fee income durability, new business momentum, and operating leverage. When revenue forecasts compress, investors often respond with multiple compression—especially when the stock has recently been pricing in steadier growth—because lower revenue assumptions can ripple into margin and capital return expectations over time, even if near-term earnings are not immediately revised at the same magnitude. (simplywall.st)

Traders will focus on whether additional firms follow with further estimate reductions or price-target trims, and whether management commentary (or upcoming datapoints tied to insurance sales, wealth flows, and market levels) stabilizes the narrative. Investors will also be watching for any incremental capital-return signals—given Manulife has recently communicated shareholder-return actions such as a normal course issuer bid—to see if buybacks provide downside support if the stock remains volatile. (stocktitan.net)